CHBT study materials
CHBT study resources

Cannulation Pain and a Patient Who Wants to Skip Biofeedback

CHBT ยท Put your knowledge to work in context.

All case studies

Cannulation Pain and a Patient Who Wants to Skip Biofeedback

Ms. L, 41, has been on hemodialysis for 8 months and reports needle pain rated 7/10 at each cannulation. She has a documented history of generalized anxiety and takes no anxiolytics. Her nephrologist referred her for biofeedback 4 weeks ago. She has attended 2 of 4 scheduled sessions, saying "it doesn't work, the pain is the same." On review, her sessions were scheduled 45 minutes after cannulation, and she practiced only during dialysis, never at home. She is now asking to stop biofeedback and "just get numbing cream."

1. What is your clinical formulation of why biofeedback appears to have failed, and what would you recommend?

Read the worked answer

Formulation: a timing and dose problem, not necessarily a treatment failure.

  • Timing mismatch: the intervention was delivered after the painful event. Biofeedback for procedural pain must be practiced before and during the anticipated stressor, not only afterward.
  • Insufficient dose and generalization: 2 sessions with no home practice is well below the threshold for skill acquisition. Skills practiced only in the chair rarely transfer to the moment of cannulation.
  • Unrealistic expectation: she may expect biofeedback to eliminate pain. It more plausibly reduces arousal and distress and may modestly raise pain tolerance.

Recommendation: do not simply discharge. Reframe expectations explicitly, move sessions to 15โ€“20 minutes before cannulation, add brief daily home practice (5 minutes), and combine with the numbing cream she requested rather than treating them as competing options. Reassess after 4โ€“6 properly timed sessions.

2. How would you discuss the numbing cream request in a way that respects her autonomy and supports informed choice?

Read the worked answer

Support the request; combine rather than replace.

  • Validate: "It makes sense to want something that directly targets the needle." Topical anesthetic is a legitimate, evidence-supported option for cannulation pain and should be raised with her care team.
  • Clarify roles honestly: the cream addresses the needle sensation; biofeedback addresses the arousal, muscle tension, and anticipatory fear that amplify pain. They work on different mechanisms and are not mutually exclusive.
  • Offer a time-limited trial with clear criteria: "Let's do both for 6 sessions and check your pain score and how you feel before cannulation. If it isn't helping, we'll change the plan."
  • Respect refusal: if she declines biofeedback after an informed discussion, document her choice and continue to support her pain management.

Ethical frame: autonomy and beneficence together - present options, avoid coercion, and avoid abandoning her because the first attempt was poorly designed.